Please use this identifier to cite or link to this item:
Title: How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017 ?
Authors: Of, Ournal
subject: Medical Science
Year: 2017
volume: Volume 35
issue: Issue 20
month: July
Appears in Collections:Journal of Clinical Oncology 2017

Files in This Item:
File Description SizeFormat 
2017 JCLIONC Volume 35 Issue 20 July (4).pdf457.7 kBAdobe PDFThumbnail
Download    Request a copy

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.